ZANDUREALT
- Series
- EQ
- F&O
- No
- Status
- Inactive since 25 Apr 2018
Formerly ZANDUPHARM (until 10 Mar 2010). Earlier name: Zandu Pharmaceutical works Ltd. (until 10 Mar 2010).
Source: NSE equity master · as of 24 Apr 2018
- 06 Apr 2018 12:20PDF · -Insider / SAST
Emami Infrastructure Limited has submitted to the Exchange a copy of disclosure under Regulation 30(1) and 30(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.
- 05 Apr 2018 16:50PDF · -Insider / SAST
Emami Infrastructure Limited has submitted to the Exchange a copy of disclosure under Regulation 30(1) and 30(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.
- 10 Apr 2017 09:02PDF · -Insider / SAST
Emami Infrastructure Limited has submitted to the Exchange vide letter dated April 04, 2017 a copy of disclosure under Regulation 30(1) and 30(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.
- 06 Apr 2017 17:28PDF · -Insider / SAST
Emami Infrastructure Limited has submitted to the Exchange a copy of disclosure under Regulation 30(1) and 30(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.
- 11 Apr 2016 17:04PDF · -Insider / SAST
Emami Rainbow Niketan Pvt. Ltd. has submitted to the Exchange vide letter dated April 6, 2016 a copy of disclosure under Regulation 30(1) and 30(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.
- 09 Apr 2015 12:34PDF · -Insider / SAST
Emami Rainbow Niketan Pvt. LTd. has submitted to the Exchange vide letter dated April 06, 2015 a copy of disclosure under Regulation 30(1) and 30(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.
- 27 Oct 2008 20:19Insider / SAST
Zandu Pharmaceutical Works Ltd. has submitted to the Exchange disclosures received in form D, as required under Regulation 13(6) of the SEBI (Prohibition of Insider Trading) Regulations, 1992. A copy of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).<a href=/content/corporate/zandupharma_Reg_27102008.zip target=NEW> For more details click here.</a>
- 26 Jun 2008 19:36Insider / SAST
Zandu Pharmaceutical Works Ltd. has informed the Exchange regarding the disclosure received by the company under Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 1992 for sale of shares from following persons. (1) PHI Consultants Pvt. Ltd. (2) Sharmila Leasing and Investments Pvt. Ltd. (3) Soraya Investment & Trading Co. P. Ltd. (4) Devkumar Vaidya, Anita Vaidya & Neena Vaidya. (5) Anita Vaidya (6) Apsara Leasing and Finance Pvt. Ltd. (7) Devkumar Vaidya & Neena Vaidya (8) Devkumar Vaidya. (9) Neena Vaidya (10) Haresh Vaidya (HUF) Karta Devkumar H. Vaidya. T
- 10 Jun 2008 11:32Insider / SAST
Zandu Pharmaceutical Works Ltd. has informed the Exchange that Company have received the initial disclosure of detail of shares held by Emami Limited in Form A vide their letter dated May 29, 2008. Company has submitted Regulation under 13(6) of the SEBI (Prohibition of Insider Trading) Regulations, 1992. The details of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).<a href=/content/corporate/zandu_Reg_10062008.zip target=NEW> For more details click here.</a>
- Results & board-meeting calendar
- Dividend, split, AGM calendar
- Headlines with source and timestamp
- Two-line factual filing summaries